Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation

Cardinal Health acquires Chinese distributer as part of new ‘growth platform’

01-Dec-2010 - US based healthcare distributer, Cardinal Health, has announced the $470m acquisition of privately held healthcare distribution business Zuellig Pharma China, known locally as Yong Yu.

Kendle op profit down 64% as early stage review nears end

10-Nov-2010 - Kendle recorded a 64 per cent drop in Q3 operating income and expects its strategic review of early stage, which will establish a fair value and consider all options, to...

Southern Research gains bioanalytical lab assets in BioCryst acquisition

19-Oct-2010 - Southern Research Institute is acquiring BioCryst Pharmaceuticals’ bioanalytical laboratory assets and personnel in a move towards expanding its bioanalytical service offerings.

BioClinica shareholder calls for managment resignations

04-Oct-2010 - BioClinica shareholder Nicusa Capital is calling for the resignation of CEO Mark Weinstein, CFO Ted Kaminer and Chairman David Nowiki, after describing the firm’s corporate strategy as “defective.”

Covance & Sanofi ink 10-year, $2.2bn strategic R&D alliance

30-Sep-2010 - Covance has inked a 10-year strategic alliance, worth up to $2.2bn, with Sanofi-Aventis and acquired two European sites from the big pharma.

DSM seeks Asian partners; welcomes J&J Crucell takeover

23-Sep-2010 - DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.

ImmunoSolv & GBC merge; plan contract services growth

01-Sep-2010 - ImmunoSolv is merging with Grampian BioConsultants (GBC) and plans to accelerate development of the contract research business.

Encorium cuts Q2 operating loss despite drop in revenue

18-Aug-2010 - Encorium cut its operating loss to $775,000 in the second quarter despite posting a 17 per cent drop in total revenue.

Cyprotex sees profits down in H1, but predicts US growth

16-Aug-2010 - Pre-clinical ADME contractor Cyprotex upbeat about 2010 despite drop in profit, citing new US opportunities post-Apredica acquisition.

India’s Lambda buys Biovail's research division

09-Aug-2010 - Contract research organization (CRO) Lambda Therapeutic Research has acquired Biovail’s contract research division.

AMRI posts $6m operating loss in Q2; plans expansions

05-Aug-2010 - AMRI recorded a $6.0m (€4.6m) operating loss in the second quarter as restructuring charges and the lack of milestone payments offset contract service gains.

Bilcare to boost EU and US access with €100m Ineos Films buy

03-Aug-2010 - Bilcare to buy Ineos’ rigid polymer films business for €100m ($132m) to improve access to pharmaceutical packaging customers worldwide.

CRL & WuXi discuss Q2 results, life after collapse of deal

03-Aug-2010 - CRL and WuXi have both vowed to independently build their capabilities, to become integrated service providers, but reported mixed financial results.

CRL abandons Wuxi takeover after shareholder opposition

30-Jul-2010 - Charles River Laboratories (CRL) has abandoned plans to buy Wuxi Pharmatech after the $1.6bn (€1.2bn) takeover failed to gain sufficient shareholder support.

Guest article

Pharma consolidation and the downstream impact on CROs

29-Jul-2010 - Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact...

Icon op income down; “pretty active” in pursuit of M&A

28-Jul-2010 - Icon reported a dip in operating income in the second quarter but an upturn in new business, and the cash to pursue M&A, make it reasonably positive about the future....

Encorium buys Progenitor for vacc biz and global reach

20-Jul-2010 - Encorium has bought Progenitor International Research, furthering efforts to fix its financial woes by focusing on vaccines, oncology and growth in emerging markets.

Jana says Wuxi deal offers inadequate returns for CRL

19-Jul-2010 - Major Charles River Laboratories (CRL) shareholder Jana Partners says Wuxi PharmaTech deal would generate inadequate returns, citing “industry” concerns about integration.

Guest article

M&A processes, pitfalls and keys to success

15-Jul-2010 - M&A can help revitalize firms but failure to properly integrate the companies can create an inefficient, demoralized business. In this article, Viq Pervaaz, senior vice president at Aon Consulting, takes...

CRL cites WuXi synergies, client support to woo investors

15-Jul-2010 - CRL has said the WuXi buy could add up to $100m (€78m) in additional annual revenue and spoken of clients’ enthusiasm for the deal as its attempts to shore up...

Sanofi looks to sell EU research sites to Covance

12-Jul-2010 - Sanofi Aventis intends to sell two of its European research facilities to US-based contract research organisation (CRO) Covance.

Aptuit to acquire GSK’s Italian R&D centre

05-Jul-2010 - Aptuit is to acquire GSK’s Italian R&D centre, take on its 500 employees and become part of the big pharma’s CRO network.

Minapharm buys CMO ProBioGen for €30.4m

17-Jun-2010 - Egypt-based Minapharm has acquired 95 per cent of CMO ProBioGen for a possible total of €30.4m ($37.6m).

Icon and Parexel partner with B-MS to support clinical dev

15-Jun-2010 - Bristol-Myers Squibb (B-MS) has inked deals with Icon and Parexel to support the large volume of clinical development work it expects to perform in coming years.

Patheon op profit up 12%

14-Jun-2010 - Patheon has posted a 12 per cent growth in operating profit in the second quarter and said there is “strong evidence” the business environment is improving.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...